Lung transplantation is an established treatment for patients with end-stage pulmonary disease from multiple causes (Orens and Garrity, 2009). The most common primary indications for adult lung transplantation identified by registry data from the International Society for Heart and Lung Transplantation (ISHLT) (n=45,689) were:
Worldwide, between January 1982 and June 2014, ISHLT registry data for combined heart and lung transplants (n=3,356), showed that the most common indications were:
Lung transplantation is associated with significant mortality and morbidity, and long-term survival is much lower than observed for patients receiving kidney, liver or heart transplants (Orens and Garrity, 2009; Fredericks et al., 2014).
Alternatively login via
Back to epgonline.org